Pro-B-type natriuretic peptide strongly predicts all cause and cardiovascular mortality in peripheral arterial disease patients with as well as in those without type 2 diabetes. (August 2018) - Zanolin, D.; Saely, C.H.; Vonbank, A.; Lins, C.; Leiherer, A.; Mader, A.; Larcher, B.; Muendlein, A.; Drexel, H.